Volume | 1,240 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Baxter International Inc | BAX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
42.69 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
15 | 1,240 | - | 31.01 - 50.21 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
07:25:10 | 87 | US$ 42.71 | USD |
Baxter (BAX) Options Flow Summary
Baxter International Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
21.68B | 507.83M | - | 14.84B | 2.66B | 5.23 | 8.16 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Baxter News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BAX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 41.98 | 42.785 | 41.245 | 41.99 | 3,783,306 | 0.70 | 1.67% |
1 Month | 41.40 | 44.005 | 40.27 | 42.22 | 3,864,184 | 1.28 | 3.09% |
3 Months | 38.16 | 44.005 | 37.87 | 40.80 | 3,782,206 | 4.52 | 11.84% |
6 Months | 37.51 | 44.005 | 31.01 | 37.26 | 4,466,299 | 5.17 | 13.78% |
1 Year | 39.89 | 50.21 | 31.01 | 40.47 | 4,656,695 | 2.79 | 6.99% |
3 Years | 85.48 | 89.70 | 31.01 | 55.55 | 3,935,061 | -42.80 | -50.07% |
5 Years | 79.29 | 95.19 | 31.01 | 64.37 | 3,515,143 | -36.61 | -46.17% |
Baxter Description
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. The company offers contract manufacturing services to pharmaceutical companies. The Hillrom transaction has added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's 2021 revenue came from more digitally connected offerings like its smart beds and Voalte medical communications app. |